Close

Magellan Health (MGLN) Tops Q4 EPS Views; Guides FY15 EPS

February 26, 2015 6:31 AM EST

Magellan Health (NASDAQ: MGLN) reported Q4 EPS of $1.32, $0.81 better than the analyst estimate of $0.51. Revenue for the quarter came in at $982.5 million versus the consensus estimate of $980.37 million.

Magellan Health sees FY2015 EPS of $3.33-$3.79, versus the consensus of $2.36.

For earnings history and earnings-related data on Magellan Health (MGLN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings